X-100599086-T-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022144.3(TNMD):c.648T>G(p.Ile216Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000333 in 1,202,634 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022144.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000901 AC: 1AN: 110954Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000112 AC: 2AN: 178179 AF XY: 0.0000159 show subpopulations
GnomAD4 exome AF: 0.00000275 AC: 3AN: 1091680Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 357346 show subpopulations
GnomAD4 genome AF: 0.00000901 AC: 1AN: 110954Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33170 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.648T>G (p.I216M) alteration is located in exon 6 (coding exon 6) of the TNMD gene. This alteration results from a T to G substitution at nucleotide position 648, causing the isoleucine (I) at amino acid position 216 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at